NO20073725L - CCI-779-polymorf og dens anvendelse - Google Patents
CCI-779-polymorf og dens anvendelseInfo
- Publication number
- NO20073725L NO20073725L NO20073725A NO20073725A NO20073725L NO 20073725 L NO20073725 L NO 20073725L NO 20073725 A NO20073725 A NO 20073725A NO 20073725 A NO20073725 A NO 20073725A NO 20073725 L NO20073725 L NO 20073725L
- Authority
- NO
- Norway
- Prior art keywords
- cci
- polymorph
- polymorphic form
- present
- provides
- Prior art date
Links
- CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 title abstract 4
- 229960000235 temsirolimus Drugs 0.000 title abstract 4
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US65137405P | 2005-02-09 | 2005-02-09 | |
| PCT/US2006/003098 WO2006086172A1 (en) | 2005-02-09 | 2006-01-25 | Cci-779 polymorph and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20073725L true NO20073725L (no) | 2007-09-05 |
Family
ID=36570939
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20073725A NO20073725L (no) | 2005-02-09 | 2007-07-18 | CCI-779-polymorf og dens anvendelse |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US7442707B2 (pt) |
| EP (1) | EP1856130A1 (pt) |
| JP (1) | JP2008530090A (pt) |
| KR (1) | KR20070107030A (pt) |
| CN (1) | CN101115759A (pt) |
| AR (1) | AR052479A1 (pt) |
| AU (1) | AU2006213061A1 (pt) |
| BR (1) | BRPI0607932A2 (pt) |
| CA (1) | CA2595766A1 (pt) |
| CR (1) | CR9257A (pt) |
| GT (1) | GT200600044A (pt) |
| IL (1) | IL184560A0 (pt) |
| MX (1) | MX2007009590A (pt) |
| NO (1) | NO20073725L (pt) |
| PE (1) | PE20060996A1 (pt) |
| RU (1) | RU2007129264A (pt) |
| TW (1) | TW200638932A (pt) |
| WO (1) | WO2006086172A1 (pt) |
| ZA (1) | ZA200706628B (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8551512B2 (en) * | 2004-03-22 | 2013-10-08 | Advanced Cardiovascular Systems, Inc. | Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS |
| WO2007067565A1 (en) * | 2005-12-07 | 2007-06-14 | Wyeth | Process for the preparation of purified crystalline cci-779 |
| TW200804399A (en) * | 2005-12-07 | 2008-01-16 | Wyeth Corp | Scalable process for the preparation of a rapamycin 42-ester from a rapamycin 42-ester boronate |
| TW200736603A (en) * | 2005-12-07 | 2007-10-01 | Wyeth Corp | Methods for preparing crystalline rapamycin and measuring crystallinity of rapamycin compounds using differential scanning calorimetry |
| TW200824713A (en) * | 2006-10-18 | 2008-06-16 | Wyeth Corp | Processes for the synthesis of individual isomers of mono-PEG CCI-779 |
| JP5643770B2 (ja) * | 2009-01-21 | 2014-12-17 | バイオコン・リミテッドＢｉｏｃｏｎ Ｌｉｍｉｔｅｄ | シロリムスの安定性の決定方法およびその安定形態の調製方法 |
| US10682415B2 (en) | 2013-07-22 | 2020-06-16 | Wisconsin Alumni Research Foundation | Thermogel formulation for combination drug delivery |
| CN109020995A (zh) * | 2017-06-12 | 2018-12-18 | 鲁南制药集团股份有限公司 | 一种替西罗莫司的晶型物 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5362718A (en) | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
| US6277983B1 (en) * | 2000-09-27 | 2001-08-21 | American Home Products Corporation | Regioselective synthesis of rapamycin derivatives |
| TWI256395B (en) | 1999-09-29 | 2006-06-11 | Wyeth Corp | Regioselective synthesis of rapamycin derivatives |
| MXPA04001523A (es) | 2001-08-22 | 2004-05-31 | Wyeth Corp | Dialdehidos de rapamicina. |
| DE60206512T2 (de) | 2001-08-22 | 2006-06-22 | Wyeth | Rapamycin 29-enole |
| CA2528173A1 (en) | 2003-07-16 | 2005-02-03 | Wyeth | Cci-779 isomer c |
| RU2339639C2 (ru) * | 2003-08-07 | 2008-11-27 | Уайт | Региоселективный синтез cci-779 |
| WO2005023254A1 (en) | 2003-09-03 | 2005-03-17 | Wyeth | Amorphous rapamycin 42-ester with 3-hydroxy-2-(hydroxymethyl)-2-methylpropionic acid and its pharmaceutical compositions containing the same |
| CA2562952A1 (en) | 2004-04-14 | 2005-11-10 | Wyeth | Regiospecific synthesis of rapamycin 42-ester derivatives |
-
2006
- 2006-01-25 AU AU2006213061A patent/AU2006213061A1/en not_active Abandoned
- 2006-01-25 BR BRPI0607932A patent/BRPI0607932A2/pt not_active IP Right Cessation
- 2006-01-25 JP JP2007555124A patent/JP2008530090A/ja not_active Withdrawn
- 2006-01-25 RU RU2007129264/04A patent/RU2007129264A/ru not_active Application Discontinuation
- 2006-01-25 MX MX2007009590A patent/MX2007009590A/es not_active Application Discontinuation
- 2006-01-25 KR KR1020077018347A patent/KR20070107030A/ko not_active Withdrawn
- 2006-01-25 EP EP06734012A patent/EP1856130A1/en not_active Withdrawn
- 2006-01-25 WO PCT/US2006/003098 patent/WO2006086172A1/en not_active Ceased
- 2006-01-25 CN CNA200680004408XA patent/CN101115759A/zh not_active Withdrawn
- 2006-01-25 CA CA002595766A patent/CA2595766A1/en not_active Abandoned
- 2006-01-25 US US11/339,728 patent/US7442707B2/en not_active Expired - Fee Related
- 2006-02-03 PE PE2006000136A patent/PE20060996A1/es not_active Application Discontinuation
- 2006-02-06 TW TW095103902A patent/TW200638932A/zh unknown
- 2006-02-07 GT GT200600044A patent/GT200600044A/es unknown
- 2006-02-08 AR ARP060100451A patent/AR052479A1/es unknown
-
2007
- 2007-07-12 IL IL184560A patent/IL184560A0/en unknown
- 2007-07-18 NO NO20073725A patent/NO20073725L/no not_active Application Discontinuation
- 2007-07-18 CR CR9257A patent/CR9257A/es not_active Application Discontinuation
- 2007-08-08 ZA ZA200706628A patent/ZA200706628B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0607932A2 (pt) | 2016-11-08 |
| GT200600044A (es) | 2006-11-09 |
| US20060178392A1 (en) | 2006-08-10 |
| CN101115759A (zh) | 2008-01-30 |
| RU2007129264A (ru) | 2009-03-20 |
| EP1856130A1 (en) | 2007-11-21 |
| ZA200706628B (en) | 2010-01-27 |
| MX2007009590A (es) | 2007-09-12 |
| AR052479A1 (es) | 2007-03-21 |
| US7442707B2 (en) | 2008-10-28 |
| CA2595766A1 (en) | 2006-08-17 |
| KR20070107030A (ko) | 2007-11-06 |
| WO2006086172A1 (en) | 2006-08-17 |
| TW200638932A (en) | 2006-11-16 |
| IL184560A0 (en) | 2007-10-31 |
| JP2008530090A (ja) | 2008-08-07 |
| PE20060996A1 (es) | 2006-11-13 |
| CR9257A (es) | 2007-11-23 |
| AU2006213061A1 (en) | 2006-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20071050L (no) | Rapamycin-polymorf II og anvendelser derav | |
| SE0301372D0 (sv) | Novel compounds | |
| ATE528989T1 (de) | Kristalline feste rasagilin-base | |
| MX2007005221A (es) | Formas cristalinas de ascomicina y preparacion de ellas. | |
| EP1765391A4 (en) | BACTERIAL COMPOSITIONS FOR THE TREATMENT OF CANCER | |
| EA200970156A1 (ru) | Пиридизиноновые производные | |
| CY1109998T1 (el) | Ενδυναμωτες υποδοχεων γλουταμινικου | |
| EA200971051A1 (ru) | Ингибиторы p70 s6 киназы | |
| SE0301373D0 (sv) | Novel compounds | |
| NO20073725L (no) | CCI-779-polymorf og dens anvendelse | |
| WO2006123113A3 (en) | Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors | |
| PL2207786T3 (pl) | 2'-fluoro-2'-deoksy tetrahydrouryny jako inhibitory dezaminazy cytydyny | |
| EA200800546A1 (ru) | Бензимидазолтиофеновые соединения в качестве ингибиторов polo-подобных киназ (plk) | |
| DK3219705T3 (da) | Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid | |
| SE0101675D0 (sv) | Novel composition | |
| EA200801998A1 (ru) | ПИРИДИН[3,4-b]ПИРАЗИНОНЫ | |
| WO2009067686A8 (en) | Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof | |
| IN2012DN03085A (pt) | ||
| MX2012002542A (es) | Compuestos y composiciones como inhibidores de cinasa de proteina. | |
| ECSP045088A (es) | Forma polimorfica de rimonabant, su procedimiento de preparacion y composiciones farmaceuticas que la contienen | |
| DK1695710T3 (da) | Krystallinsk betad-form af ivabradinhydrochlorid, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende denne | |
| CL2008000021A1 (es) | Compuestos derivados de 2,4-dianilinopirimidinas, inhibidores de proteinas cinasas; procedimiento de preparacion; composicion farmaceutica; y uso para el tratamiento o prevencion de enfermedades inflamatorias, diabetes y cancer. | |
| WO2007064553A3 (en) | Thiazole derivatives as cxcr3 receptor modulators | |
| NO20060392L (no) | Kombinasjon av SRC kinase inhibitorer kemoterapeutiske midler for behandling av proliferative sykdommer | |
| WO2007066337A3 (en) | Jasmonate derivatives, pharmaceutical compositions and methods of use thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |